Alexipharmic Drugs Market to Reach USD 6.25 Billion by 2034 Driven by Rising Incidence of Poisoning and Growing Investment in Antidote Research
The Alexipharmic Drugs Market, estimated at USD 3.70 billion in 2024, is expected to grow at a healthy CAGR of 5.40% during the forecast period, reaching approximately USD 6.25 billion by 2034. According to Alexipharmic Drugs Market Industry Analysis, the increasing number of poisoning cases, industrial accidents, and venomous animal bites are pushing demand for...
0 Commentaires
0 parts
English
Dutch